Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling ; volume:10 ; number:1 ; day:24 ; month:8 ; year:2023 ; pages:1-18 ; date:12.2023
EJNMMI Physics ; 10, Heft 1 (24.8.2023), 1-18, 12.2023
- Creator
-
Siebinga, Hinke
Wit-van der Veen, Berlinda J. de
Beijnen, Jos H.
Stokkel, Marcel P. M.
Dorlo, Thomas P. C.
Huitema, Alwin D. R.
Hendrikx, Jeroen J. M. A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-023-00565-4
- URN
-
urn:nbn:de:101:1-2023110609534927878785
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Siebinga, Hinke
- Wit-van der Veen, Berlinda J. de
- Beijnen, Jos H.
- Stokkel, Marcel P. M.
- Dorlo, Thomas P. C.
- Huitema, Alwin D. R.
- Hendrikx, Jeroen J. M. A.
- SpringerLink (Online service)
Other Objects (12)
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE